BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

907 related articles for article (PubMed ID: 34400495)

  • 1. Redox imbalance links COVID-19 and myalgic encephalomyelitis/chronic fatigue syndrome.
    Paul BD; Lemle MD; Komaroff AL; Snyder SH
    Proc Natl Acad Sci U S A; 2021 Aug; 118(34):. PubMed ID: 34400495
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insights from myalgic encephalomyelitis/chronic fatigue syndrome may help unravel the pathogenesis of postacute COVID-19 syndrome.
    Komaroff AL; Lipkin WI
    Trends Mol Med; 2021 Sep; 27(9):895-906. PubMed ID: 34175230
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic risk factors for severe and fatigue dominant long COVID and commonalities with ME/CFS identified by combinatorial analysis.
    Taylor K; Pearson M; Das S; Sardell J; Chocian K; Gardner S
    J Transl Med; 2023 Nov; 21(1):775. PubMed ID: 37915075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exercise Pathophysiology in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome and Postacute Sequelae of SARS-CoV-2: More in Common Than Not?
    Joseph P; Singh I; Oliveira R; Capone CA; Mullen MP; Cook DB; Stovall MC; Squires J; Madsen K; Waxman AB; Systrom DM
    Chest; 2023 Sep; 164(3):717-726. PubMed ID: 37054777
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Post-exertional malaise among people with long COVID compared to myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS).
    Vernon SD; Hartle M; Sullivan K; Bell J; Abbaszadeh S; Unutmaz D; Bateman L
    Work; 2023; 74(4):1179-1186. PubMed ID: 36911963
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence for Peroxisomal Dysfunction and Dysregulation of the CDP-Choline Pathway in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.
    Che X; Brydges CR; Yu Y; Price A; Joshi S; Roy A; Lee B; Barupal DK; Cheng A; Palmer DM; Levine S; Peterson DL; Vernon SD; Bateman L; Hornig M; Montoya JG; Komaroff AL; Fiehn O; Lipkin WI
    medRxiv; 2022 Jan; ():. PubMed ID: 35043127
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiovascular and haematological pathology in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS): A role for viruses.
    Nunes JM; Kell DB; Pretorius E
    Blood Rev; 2023 Jul; 60():101075. PubMed ID: 36963989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Orthostatic Symptoms and Reductions in Cerebral Blood Flow in Long-Haul COVID-19 Patients: Similarities with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.
    Campen CLMCV; Rowe PC; Visser FC
    Medicina (Kaunas); 2021 Dec; 58(1):. PubMed ID: 35056336
    [No Abstract]   [Full Text] [Related]  

  • 9. Chronic inflammation, neuroglial dysfunction, and plasmalogen deficiency as a new pathobiological hypothesis addressing the overlap between post-COVID-19 symptoms and myalgic encephalomyelitis/chronic fatigue syndrome.
    Chaves-Filho AM; Braniff O; Angelova A; Deng Y; Tremblay MÈ
    Brain Res Bull; 2023 Sep; 201():110702. PubMed ID: 37423295
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of post COVID-19 condition and its overlap with myalgic encephalomyelitis/chronic fatigue syndrome.
    Sukocheva OA; Maksoud R; Beeraka NM; Madhunapantula SV; Sinelnikov M; Nikolenko VN; Neganova ME; Klochkov SG; Amjad Kamal M; Staines DR; Marshall-Gradisnik S
    J Adv Res; 2022 Sep; 40():179-196. PubMed ID: 36100326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long COVID in pediatrics-epidemiology, diagnosis, and management.
    Toepfner N; Brinkmann F; Augustin S; Stojanov S; Behrends U
    Eur J Pediatr; 2024 Apr; 183(4):1543-1553. PubMed ID: 38279014
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of circulating biomarkers with illness severity measures differentiates myalgic encephalomyelitis/chronic fatigue syndrome and post-COVID-19 condition: a prospective pilot cohort study.
    Domingo JC; Battistini F; Cordobilla B; Zaragozá MC; Sanmartin-Sentañes R; Alegre-Martin J; Cambras T; Castro-Marrero J
    J Transl Med; 2024 Apr; 22(1):343. PubMed ID: 38600563
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improvement of Long COVID symptoms over one year.
    Oliveira CR; Jason LA; Unutmaz D; Bateman L; Vernon SD
    Front Med (Lausanne); 2022; 9():1065620. PubMed ID: 36698810
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Post-COVID syndrome with fatigue and exercise intolerance: myalgic encephalomyelitis/chronic fatigue syndrome].
    Renz-Polster H; Scheibenbogen C
    Inn Med (Heidelb); 2022 Aug; 63(8):830-839. PubMed ID: 35925074
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bioinformatics and systems biology approach to identify the pathogenetic link of Long COVID and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.
    Lv Y; Zhang T; Cai J; Huang C; Zhan S; Liu J
    Front Immunol; 2022; 13():952987. PubMed ID: 36189286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term neuromuscular consequences of SARS-Cov-2 and their similarities with myalgic encephalomyelitis/chronic fatigue syndrome: results of the retrospective CoLGEM study.
    Retornaz F; Rebaudet S; Stavris C; Jammes Y
    J Transl Med; 2022 Sep; 20(1):429. PubMed ID: 36153556
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical Characteristics of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) Diagnosed in Patients with Long COVID.
    Tokumasu K; Honda H; Sunada N; Sakurada Y; Matsuda Y; Yamamoto K; Nakano Y; Hasegawa T; Yamamoto Y; Otsuka Y; Hagiya H; Kataoka H; Ueda K; Otsuka F
    Medicina (Kaunas); 2022 Jun; 58(7):. PubMed ID: 35888568
    [No Abstract]   [Full Text] [Related]  

  • 18. Cognitive impairment in post-acute sequelae of COVID-19 and short duration myalgic encephalomyelitis patients is mediated by orthostatic hemodynamic changes.
    Day H; Yellman B; Hammer S; Rond C; Bell J; Abbaszadeh S; Stoddard G; Unutmaz D; Bateman L; Vernon SD
    Front Neurosci; 2023; 17():1203514. PubMed ID: 37434760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Orthostatic Challenge Causes Distinctive Symptomatic, Hemodynamic and Cognitive Responses in Long COVID and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.
    Vernon SD; Funk S; Bateman L; Stoddard GJ; Hammer S; Sullivan K; Bell J; Abbaszadeh S; Lipkin WI; Komaroff AL
    Front Med (Lausanne); 2022; 9():917019. PubMed ID: 35847821
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transient receptor potential melastatin 3 dysfunction in post COVID-19 condition and myalgic encephalomyelitis/chronic fatigue syndrome patients.
    Sasso EM; Muraki K; Eaton-Fitch N; Smith P; Lesslar OL; Deed G; Marshall-Gradisnik S
    Mol Med; 2022 Aug; 28(1):98. PubMed ID: 35986236
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 46.